Overview
This educational activity will focus on local and regionally available cardiac imaging modalities and how to leverage the best tests for patients with suspected cardiac diseases. The role of multimodality imaging in myocardial viability will be reviewed and the utility of viability assessment in guiding management will be discussed. The course will also cover cardiac amyloid nuclear imaging and illustrate the best tests to confirm an unexpected diagnosis.
Target Audience
This educational activity will target physicians (general cardiologists, nuclear medicine physicians, radiologists, cardiology fellows, referring physicians).
Learner Objectives
After participating in this activity, learners should be able to achieve the following:
• Describe the diagnostic and treatment options available in the Asia-Pacific/Oceania region
• Discuss regional and local guidelines in managing COVID-19 scenarios in the cardiac nuclear lab
• Describe new uses for an old nuclear agent, PYP cardiac imaging
• Evaluate myocardial viability with the technologies that are available locally
Overall Goal
The overall goal of this activity is to improve knowledge and understanding of locally available diagnostic and treatment options in the Asia-Pacific/Oceania region; improve patient quality of life and outcomes by utilizing the best nuclear imaging technologies locally available; and improve the safety and efficiency of operating a cardiac nuclear lab during the COVID-19 pandemic.
Continuing Education Term of Approval
Release Date: May 27, 2022
Expiration Date: August 27, 2022
Method of Participation
This activity is a virtual course that took place on May 26, 2022. On Demand content available to learner's includes a recording of the full webinar, PDF's of the presentations and a faculty evaluation.
Medium and Software Requirements
Windows Requirements:
Operating system: Windows 10+
Browser: Chrome v90.0+, Firefox v84.0+, Edge v90.0+
Internet connection: DSL, cable modem, or other high-speed connection
Macintosh Requirements:
Operating system: Mac OS X 10.6.8+
Browser: Mozilla Firefox v84.0+, Safari 14+, Chrome v90.0+
Internet connection: DSL, cable modem, or other high-speed connection